Spero Therapeutics, Inc. (SPRO) News
Track canonical SquawkNews coverage tagged to SPRO, Spero Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Spero Therapeutics announces Nasdaq inducement grant under Rule 5635(c)(4)
Spero Therapeutics announced an inducement grant under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 03, 2026, 08:08 PM UTC
L
Spero Therapeutics board compensation committee approves inducement grant
Spero Therapeutics says its Compensation Committee approved an inducement grant under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 03, 2026, 08:08 PM UTC
L
SPRO - Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
SPRO - Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 02, 2026, 08:01 PM UTC
M
Spero Therapeutics launches $100M ATM program with Jefferies
Spero Therapeutics has launched a new at-the-market (ATM) program with Jefferies for up to $100 million.
EQUITY | Aug 28, 2026, 09:35 PM UTC
L
Spero Therapeutics may offer up to $300 million in securities
Spero Therapeutics filed with the SEC, saying it may offer up to $300 million in securities.
REGULATION | Aug 28, 2026, 09:09 PM UTC
L
SPRO Announces Q2 2026 Operating Results
Spero Therapeutics announces second quarter 2026 operating results and provides business update
EARNINGS | Aug 12, 2026, 08:01 PM UTC
L
SPRO - Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
SPRO - Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
EARNINGS | Aug 04, 2026, 08:01 PM UTC
H
Sector Update: Healthcare Stocks Mixed Premarket Tuesday
() -- Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3% and the iShares Biotechnology ETF (IBB) 0.1% higher. HCA Healthcare (HCA) shares were down mo
EARNINGS | Jul 14, 2026, 01:16 PM UTC
L
SPRO IVBIY innovent Biologics and Spero Therapeutics announce exclusive license for ibi355 (sp001), a phase 2-ready third-generation anti-cd
SPRO IVBIY innovent Biologics and Spero Therapeutics announce exclusive license for ibi355 (sp001), a phase 2-ready third-generation anti-cd40l antibody Innovent Biologics - Spero receives exclusive global rights to ibi3
GEOPOLITICS | Jul 14, 2026, 10:26 AM UTC
H
Spero Therapeutics Announces $105M In Non-Recourse Non-Dilutive Royalty Financing With KKR's Healthcare Royalty
Financing supports Phase 2 development of SP001, Spero’s first immunology drug candidate, in-licensed from Innovent Biologics Transaction unlocks immediate value from future Utebzi (tebipenem pivoxil) milestones and roya
EARNINGS | Jul 14, 2026, 10:11 AM UTC